Literature DB >> 24366037

Potent, selective small molecule inhibitors of type III phosphatidylinositol-4-kinase α- but not β-inhibit the phosphatidylinositol signaling cascade and cancer cell proliferation.

Michael J Waring1, David M Andrews, Paul F Faulder, Vikki Flemington, Jennifer C McKelvie, Sarita Maman, Marian Preston, Piotr Raubo, Graeme R Robb, Karen Roberts, Rachel Rowlinson, James M Smith, Martin E Swarbrick, Iris Treinies, Jon J G Winter, Robert J Wood.   

Abstract

Two series of inhibitors of type III phosphatidylinositol-4-kinase were identified by high throughput screening and optimised to derive probe compounds that independently and selectively inhibit the α- and the β-isoforms with no significant activity towards related kinases in the pathway. In a cellular environment, inhibition of the α- but not the β-subtype led to a reduction in phosphatidylinositol-4-phosphate and phosphatidylinositol-4,5-bisphosphate concentration, causing inhibition of inositol-1-phosphate formation and inhibition of proliferation in a panel of cancer cell lines.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24366037     DOI: 10.1039/c3cc48391f

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  11 in total

1.  Foot-and-mouth disease virus genome replication is unaffected by inhibition of type III phosphatidylinositol-4-kinases.

Authors:  Eleni-Anna Loundras; Morgan R Herod; Mark Harris; Nicola J Stonehouse
Journal:  J Gen Virol       Date:  2016-06-20       Impact factor: 3.891

2.  Components of the phosphatidylserine endoplasmic reticulum to plasma membrane transport mechanism as targets for KRAS inhibition in pancreatic cancer.

Authors:  Walaa E Kattan; Junchen Liu; Dina Montufar-Solis; Hong Liang; Bhargavi Brahmendra Barathi; Ransome van der Hoeven; Yong Zhou; John F Hancock
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-21       Impact factor: 12.779

3.  Design and Structural Characterization of Potent and Selective Inhibitors of Phosphatidylinositol 4 Kinase IIIβ.

Authors:  Florentine U Rutaganira; Melissa L Fowler; Jacob A McPhail; Michael A Gelman; Khanh Nguyen; Anming Xiong; Gillian L Dornan; Brandon Tavshanjian; Jeffrey S Glenn; Kevan M Shokat; John E Burke
Journal:  J Med Chem       Date:  2016-02-26       Impact factor: 7.446

4.  Amplification of Chromosome 1q Genes Encoding the Phosphoinositide Signalling Enzymes PI4KB, AKT3, PIP5K1A and PI3KC2B in Breast Cancer.

Authors:  Mark G Waugh
Journal:  J Cancer       Date:  2014-10-28       Impact factor: 4.207

5.  Novel phosphatidylinositol 4-kinases III beta (PI4KIIIβ) inhibitors discovered by virtual screening using free energy models.

Authors:  Natalie M Colodette; Lucas S Franco; Rodolfo C Maia; Harold H Fokoue; Carlos Mauricio R Sant'Anna; Eliezer J Barreiro
Journal:  J Comput Aided Mol Des       Date:  2020-06-30       Impact factor: 3.686

6.  Targeting plasma membrane phosphatidylserine content to inhibit oncogenic KRAS function.

Authors:  Walaa E Kattan; Wei Chen; Xiaoping Ma; Tien Hung Lan; Dharini van der Hoeven; Ransome van der Hoeven; John F Hancock
Journal:  Life Sci Alliance       Date:  2019-08-26

Review 7.  Discovery of the Hedgehog Pathway Inhibitor Pipinib that Targets PI4KIIIß.

Authors:  Lea Kremer; Elisabeth Hennes; Alexandra Brause; Andrei Ursu; Lucas Robke; Hideaki T Matsubayashi; Yuta Nihongaki; Jana Flegel; Ivana Mejdrová; Jan Eickhoff; Matthias Baumann; Radim Nencka; Petra Janning; Susanne Kordes; Hans R Schöler; Jared Sterneckert; Takanari Inoue; Slava Ziegler; Herbert Waldmann
Journal:  Angew Chem Int Ed Engl       Date:  2019-10-04       Impact factor: 15.336

8.  PtdIns4KIIα generates endosomal PtdIns(4)P and is required for receptor sorting at early endosomes.

Authors:  Yuji Henmi; Yoshiaki Morikawa; Natsuko Oe; Narumi Ikeda; Akikazu Fujita; Kohji Takei; Shane Minogue; Kenji Tanabe
Journal:  Mol Biol Cell       Date:  2016-01-28       Impact factor: 4.138

9.  Purine analogs as phosphatidylinositol 4-kinase IIIβ inhibitors.

Authors:  Michal Šála; Martin Kögler; Pavla Plačková; Ivana Mejdrová; Hubert Hřebabecký; Eliška Procházková; Dmytro Strunin; Gary Lee; Gabriel Birkus; Jan Weber; Helena Mertlíková-Kaiserová; Radim Nencka
Journal:  Bioorg Med Chem Lett       Date:  2016-04-05       Impact factor: 2.823

Review 10.  RAS Nanoclusters Selectively Sort Distinct Lipid Headgroups and Acyl Chains.

Authors:  Yong Zhou; Alemayehu A Gorfe; John F Hancock
Journal:  Front Mol Biosci       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.